Company: Rakovina Therapeutics, Inc.
Job title: President and CSO
Harnessing Organoids & Spheroids to Advance DDR Therapeutic Insights for Ewing Sarcoma 3:30 pm
• Highlighting the advantages of organoids and spheroids in recapitulating the tumour microenvironment, genetic heterogeneity, and therapeutic responses of Ewing sarcoma • Discussing strategies to enhance the translational relevance of these models, such as incorporating patient-derived cells, genetic profiling, and integration of immune components • Exploring innovative approaches, such as 3D bioprinting, to improve the…Read more
day: Conference Day Two